ERLOTINIB EG 100 mg, comprimé pelliculé — plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930111888 -
CIP7
3011188 -
CIS
68366100
What the source publishes
- Holder
- EG LABO - LABORATOIRES EUROGENERICS
- Active ingredients
- CHLORHYDRATE D'ERLOTINIB, ERLOTINIB
- Form
- comprimé pelliculé
- Package
- plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2018-02-06
- Prescription
- Prescription or restricted
Names this record is found by
- ERLOTINIB EG 100 mg, comprimé pelliculé — plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)
- ERLOTINIB EG 100 mg, comprimé pelliculé
- CHLORHYDRATE D'ERLOTINIB
- ERLOTINIB
Complete source data
{
"cis": "68366100",
"cip7": "3011188",
"form": "comprimé pelliculé",
"name": "ERLOTINIB EG 100 mg, comprimé pelliculé — plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)",
"cip13": "3400930111888",
"holder": "EG LABO - LABORATOIRES EUROGENERICS",
"routes": [
"orale"
],
"holders": [
"EG LABO - LABORATOIRES EUROGENERICS"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "695.72",
"authorisedOn": "2018-02-06",
"compositions": [
{
"name": "CHLORHYDRATE D'ERLOTINIB",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "27387",
"dosageReference": null,
"pharmaceuticalElement": "comprimé"
},
{
"name": "ERLOTINIB",
"nature": "FT",
"strength": "100 mg",
"linkageNumber": "1",
"substanceCode": "56421",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "694.70",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ERLOTINIB EG 100 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) aluminium OPA : polyamide orienté PVC de 30 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100 %"
],
"marketingDeclaredOn": "2020-03-27",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE D'ERLOTINIB",
"ERLOTINIB"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930111888"